Risk estimates for decreased ADAMTS13 activity ranged from a 0.5-fold to an 8.2-fold increased risk of myocardial infarction and ranged from a 1.7-fold to a 7.3-fold increased risk of stroke [14]. This evidence concerns the gene ADAMTS13 and Stroke.